Inactivated enzyme variants and associated process and reagent system

• US 7,172,890 B2
• Filed: 10/28/2004
• Issued: 02/06/2007
• Est. Priority Date: 10/28/2004
• Status: Expired due to Fees

• Current Assignee: Roche Diabetes Care Inc. (Roche Holding AG)
• Original Assignee: Roche Diagnostics GmbH (Roche Holding AG)
• Inventors: Hoenes, Joachim, Horn, Carina, Knappe, Wolfgang-Reinhold, Schmuck, Rainer, Shao, Zhixin
• Primary Examiner(s): Prouty; Rebecca E.
• Assistant Examiner(s): MEAH, MOHAMMAD Y
• Application Number:
  US10/975,697
• Publication Number:
  US 20060094099A1
• Time in Patent Office: 831 Days
• Field of Search: 435/189, 435/69.1
• US Class Current: 435/190
• CPC Class Codes: C12N 9/0004 Oxidoreductases (1.)
• CPC Class Codes: C12N 9/0006 acting on CH-OH groups as donors (1.1)

Abstract

The present invention relates to oxidoreductase apoenzyme variants which are enzymatically inactive but have coenzyme-binding properties. Further, the present invention relates to DNA sequences encoding these oxidoreductase apoenzyme variants, expression vectors containing such DNA sequences and the use of these oxidoreductase apoenzyme variants in diagnostic applications.

Claims

1. A glucose dehydrogenase variant having about 3% or less residual enzymatic activity relative to the wild type enzyme and which retains about 20% or more of the coenzyme binding activity of the wild type enzyme, wherein said variant comprises an amino acid substitution at position 145 or 158 of the amino acid sequence of SEQ ID NO:

6 of B. subtilis.

2. The glucose dehydrogenase variant as claimed in claim 1, wherein the coenzyme is NAD(P)H.

3. The glucose dehydrogenase variant as claimed in claim 1 which has a threonine substitution at position 145 or a phenylalanine substitution at position 158 of the amino acid sequence of SEQ ID NO:

6 of B. subtilis.

4. The glucose dehydrogenase variant as claimed in claim 3, having fused thereto an amino acid segment capable of forming a metal chelate.

5. The glucose dehydrogenase variant as claimed in claim 4, wherein the amino acid sequence of said variant comprises the sequence of SEQ ID NO:

14.

6. A glucose dehydrogenase variant comprising the amino acid sequence as shown in SEQ ID NO:

8.

7. The glucose dehydrogenase of claim 6 further comprising an amino acid sequence fused thereto that is capable of forming a metal chelate.

8. A glucose dehydrogenase variant comprising the amino acid sequence as shown in SEQ ID NO:

10.

9. The glucose dehydrogenase of claim 8 further comprising an amino acid sequence fused thereto that is capable of forming a metal chelate.